Category: Uncategorized
Regulatory Update – Feb 2020
FDA: Promotional Labelling and Advertising Considerations for Prescription Biological Reference and Biosimilar Products Questions and Answers (Draft guidance) Read More…
Critical Role Of Labelling Management In Regulatory Affairs
Andy Thornley PhD, Senior Regulatory Consultant Overview Labelling for human healthcare products (i.e. medical devices, medicines, cosmetics, vitamins, and dietary
Regulatory Update – January 2020
EC: Guidance on cybersecurity for medical devices Read More… Finland: Supervision of medical devices will be transferred from Valvira to